Biogen (BIIB) Deferred Taxes (2009 - 2026)

Biogen (BIIB) has reported Deferred Taxes for 18 consecutive years, with $23.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Deferred Taxes rose 184.89% year-over-year to $23.6 million; the TTM figure through Mar 2026 stood at $413.0 million (up 282.91% YoY), while the FY2025 annual figure was $361.6 million, up 328.72% from the prior year.
• Deferred Taxes came in at $23.6 million for Q1 2026 at Biogen, down from $166.9 million in the prior quarter.
• The five-year high for Deferred Taxes was $253.8 million in Q3 2025, with the low at -$206.8 million in Q3 2023.
• Average Deferred Taxes over 5 years is -$14.5 million, with a median of -$31.3 million recorded in 2025.
• Across the five-year window, Deferred Taxes tumbled 6550.0% in 2023 and jumped 582.51% in 2025, its largest moves.
• Year by year, Deferred Taxes stood at -$28.8 million in 2022, then surged by 349.65% to $71.9 million in 2023, then tumbled by 181.22% to -$58.4 million in 2024, then jumped by 385.79% to $166.9 million in 2025, then plunged by 85.86% to $23.6 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered $23.6 million, $166.9 million, and $253.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.